Awakn Life Sciences Corp. (OTCMKTS:AWKNF – Get Free Report) traded up 28.5% during trading on Thursday . The stock traded as high as $0.11 and last traded at $0.11. 3,155 shares were traded during trading, a decline of 78% from the average session volume of 14,188 shares. The stock had previously closed at $0.08.
Awakn Life Sciences Stock Up 28.5 %
The firm’s fifty day moving average price is $0.08 and its 200 day moving average price is $0.10.
Awakn Life Sciences Company Profile
Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD.
Read More
- Five stocks we like better than Awakn Life Sciences
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Does A&F’s Q2 Earnings Win Point to a Strong Holiday Season?
- How is Compound Interest Calculated?
- Best Buy Stock Flashes Bullish Signal, Challenges Remain
- Do ETFs Pay Dividends? What You Need to Know
- Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results
Receive News & Ratings for Awakn Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Awakn Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
